Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • suludana
    Member
    • May 2008
    • 61

    #1

    Some doubts

    Hi,

    I have some doubts about Illumina-Solexa sequencing that I want to expose:


    Which is the function of the long and not complementary part of primer1?

    Which are the sequences of the oligos on the flow cell?

    What kind of purification I must do in the first PCR product?

    Thanks

    S
  • suludana
    Member
    • May 2008
    • 61

    #2
    Still...Some doubts

    Hi,

    I post this thread last week but I did not recive any reply. I insist:


    I have some doubts about Illumina-Solexa sequencing that I want to expose:


    Which is the function of the long and not complementary part of primer1?

    Which are the sequences of the oligos on the flow cell?

    What kind of purification I must do in the first PCR product?

    Thanks

    S

    Comment

    • ECO
      --Site Admin--
      • Oct 2007
      • 1360

      #3
      Hey suludana! Thanks for the posts. I've merged them together to avoid clutter, I'm sure someone will answer eventually.

      Comment

      • csquared
        Member
        • May 2008
        • 67

        #4
        Which is the function of the long and not complementary part of primer1?

        Hybridize to the flowcell.

        Which are the sequences of the oligos on the flow cell?

        See above

        What kind of purification I must do in the first PCR product?

        Lots of options here. There is the method described in the protocol (Qiagen kit), you can use a magnetic bead protocol or even a precipitation.
        HudsonAlpha Institute for Biotechnology
        http://www.hudsonalpha.org/gsl

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        20 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...